Rezolute, Inc.: Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to com ...
Finanznachrichten5m
Norges Bank - Form 8.3 - International Paper Company
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Norges Bank (b) Owner or controller of ...
Alliance Entertainment Reports Fourth Quarter and Fiscal Year 2024 Results
Operational efficiencies and margin improvements drive profitability turnaround Higher-margin DTC sales increased to 36% of gross revenue in FY24 Strengthened balance sheet with 45% reduction in revol ...
Village Super Market, Inc.: Village Super Market Announces Forthcoming Change in Chief Executive Officer and Chairman of the Board of Directors
Village Super Market, Inc. (NSD-VLGEA) today announced that Robert Sumas has notified the Board of Directors of his decision to step down as Chief ...
UniFirst Corporation Announces Leadership Changes: Kelly Rooney Named Chief Operating Officer and Michael Croatti to Transition from Executive Role
UniFirst Corporation (NYSE: UNF), a North American leader in the supply and servicing of uniform and workwear programs, facility service products ...
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the Phase 2 clinical trial Results to be presented at the ...
FedEx Reports First Quarter Diluted EPS of $3.21 and Adjusted Diluted EPS of $3.60
FedEx Corp. (NYSE: FDX) today reported the following consolidated results for the first quarter ended August 31 (adjusted measures exclude the item listed below): ...
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
Bright Green Corporation (Nasdaq: BGXX) ("Bright Green" or the "Company"), today announced that trading of its shares have been suspended from the ...
GENFIT S.A.: GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen's Iqirvo® (elafibran ...
Biodexa Pharmaceuticals PLC: ADR Ratio Change
ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company ...
Evoke Pharma, Inc.: Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with ...
iPower, Inc.: iPower Reports Fiscal Fourth Quarter and Full Year 2024 Results
Optimization Initiatives Drive Material Gross Margin Expansion and Second Consecutive Quarter of Profitability iPower Management to Host Conference Call Today at 4:30 p.m. Eastern Time RANCHO CUCAMONG ...